# Fludrocortisone Dose Response Relationship in Septic Shock - FluDReSS

> **NCT04494789** · PHASE2 · COMPLETED · sponsor: **The George Institute** · enrollment: 155 (actual)

## Conditions studied

- Critically Ill
- Septic Shock

## Interventions

- **DRUG:** Fludrocortisone Acetate
- **DRUG:** Fludrocortisone Acetate
- **DRUG:** Fludrocortisone Acetate
- **OTHER:** Standard Therapy

## Key facts

- **NCT ID:** NCT04494789
- **Lead sponsor:** The George Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-02-11
- **Primary completion:** 2023-04-30
- **Final completion:** 2023-06-30
- **Target enrollment:** 155 (ACTUAL)
- **Last updated:** 2024-01-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04494789

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04494789, "Fludrocortisone Dose Response Relationship in Septic Shock - FluDReSS". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04494789. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*